Akanksha Behl

Statistics

Publications

Citations

328

H-Index

Active since

2014

Affiliations

Indian Institute of Integrative Medicine(Current)

Maharshi Dayanand University

Indian Institute of Chemical Technology

National Dairy Research Institute

City University of New York

Akanksha Behl is an author at Indian Institute of Integrative Medicine specializing in pharmacology, nanoparticle formulations, and anticancer activity.

ORCID

Publications per year

2014–2022

Publications

A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in human colon cancer HCT-116 cells

Zahoor A. Wani, Santosh Kumar Guru, Alka Rao et al. · Food and Chemical Toxicology · 2015 · 90 citations

Life Sciences, Oncology, Pharmacology +14

Biodegradable diblock copolymeric PEG-PCL nanoparticles: Synthesis, characterization and applications as anticancer drug delivery agents

Akanksha Behl, Virinder S. Parmar, Shashwat Malhotra et al. · Polymer · 2020 · 90 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Design and Synthesis of Antitumor Heck-Coupled Sclareol Analogues: Modulation of BH3 Family Members by SS-12 in Autophagy and Apoptotic Cell Death

Shakeel-u-Rehman, Bilal Rah, Shabir H. Lone et al. · Journal of Medicinal Chemistry · 2015 · 42 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer

Akanksha Behl, Subhash Solanki, Shravan Kumar Paswan et al. · Journal of Polymers and the Environment · 2022 · 34 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer

Asif Khurshid Qazi, Aashiq Hussain, Saima Habib Khan et al. · Cancer Letters · 2014 · 29 citations

Medicine, Oncology, Pharmacology +14

1–5 of 7